You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LN≥4

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

Recruiting
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023

18F-LN1 PET/CT in Urothelial Carcinomas

Recruiting
  • Urothelial Carcinoma
    • Chengdu, Sichuan, China
      Departments of Nuclear Medicine, Sichuan Provincial People's Hos
    Nov 2, 2023

    Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)

    Recruiting
    • Bone Sarcoma
    • +15 more
    • Aldesleukin
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 3, 2022

    Artificial Intelligence, Endobronchial Ultrasound, Elastography Trial in Hamilton (EBUS-Elastography)

    Completed
    • Artificial Intelligence
    • +4 more
    • EBUS-Elastography
    • Hamilton, Ontario, Canada
      St. Joseph's Healthcare Hamilton
    Jul 25, 2022

    Metastatic Non Small Cell Lung Cancer Trial in Canada, Netherlands, United States (LN-145)

    Recruiting
    • Metastatic Non Small Cell Lung Cancer
    • LN-145
    • Duarte, California
    • +40 more
    Oct 20, 2022

    Lupus Nephritis Trial in Worldwide (ianalumab s.c. q4w, ianalumab s.c. q12w, s.c.)

    Recruiting
    • Lupus Nephritis
    • ianalumab s.c. q4w
    • +2 more
    • Fairfax, Virginia
    • +37 more
    Oct 14, 2022

    Folic Acid Clinical Trial: Follow up of Children (FACT 4 Child)

    Enrolling by invitation
    • Autism Spectrum Disorder
    • +6 more
    • SRS 2, CBCL, BRIEF-P
    • Penrith, New South Wales, Australia
    • +57 more
    Sep 18, 2022

    Head Neck Cancer Trial in United Kingdom (recombinant thyroid-stimulating hormone, Radiodine ablation without rhTSH)

    Active, not recruiting
    • Head and Neck Cancer
    • recombinant thyroid-stimulating hormone
    • Radiodine ablation without rhTSH
    • Brighton, England, United Kingdom
    • +24 more
    Oct 13, 2021

    Metastatic Melanoma, Squamous Cell Carcinoma of the Head and Neck, NSCLC Trial in Worldwide (Lifileucel, LN-145, Pembrolizumab)

    Recruiting
    • Metastatic Melanoma
    • +2 more
    • Lifileucel
    • +5 more
    • La Jolla, California
    • +44 more
    Dec 16, 2022

    Breast Cancer Trial in Worldwide (LEE011, Letrozole, BYL719)

    Active, not recruiting
    • Breast Cancer
    • San Diego, California
    • +23 more
    Feb 17, 2022

    Lupus Nephritis Trial in Alexandria (Dapagliflozin 10mg Tab orally once daily)

    Not yet recruiting
    • Lupus Nephritis
    • Dapagliflozin 10mg Tab orally once daily
    • Alexandria, Egypt
      Ain Shams University
    Oct 27, 2023

    Psychological Impact of COVID-19 on Intensive Care Survivors

    Recruiting
    • COVID-19
    • +5 more
      • Truro, Cornwall, United Kingdom
      • +44 more
      Oct 26, 2021

      Acute Myocardial Infarction, Heart Failure Trial in Sweden, United Kingdom (Dapagliflozin, Placebo)

      Recruiting
      • Acute Myocardial Infarction
      • Heart Failure
      • Alingsås, Sweden
      • +112 more
      Aug 18, 2022

      Neovascular (Wet) Age-related Macular Degeneration (AMD) Trial in United Kingdom (Stereotactic radiotherapy (16 Gray or Sham),

      Active, not recruiting
      • Neovascular (Wet) Age-related Macular Degeneration (AMD)
      • Stereotactic radiotherapy (16 Gray or Sham)
      • 0.5 mg ranibizumab
      • Huntingdon, Cambridgeshire, United Kingdom
      • +29 more
      Apr 1, 2022

      NSTEMI - Non-ST Segment Elevation MI Trial in United Kingdom (Coronary Angiography, Coronary revascularisation, Optimal Medical

      Recruiting
      • NSTEMI - Non-ST Segment Elevation MI
      • Coronary Angiography
      • +2 more
      • Wakefield, West Yorkshire, United Kingdom
      • +41 more
      Mar 8, 2022

      Metastatic Bladder Urothelial Carcinoma, Metastatic Renal Pelvis Urothelial Carcinoma, Metastatic Ureter Urothelial Carcinoma

      Withdrawn
      • Metastatic Bladder Urothelial Carcinoma
      • +5 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Dec 27, 2019

      Thyroglobulin Point of Care Assay for Rapid Detection of

      Recruiting
      • Differentiated Thyroid Cancer
      • Lymph Node Metastases
      • Point of care assay for thyroglobulin (POC-Tg) evaluation of a suspected cervical lymph node
      • Ashkelon, Israel
      • +2 more
      Oct 25, 2022

      Breast Cancer Trial in Worldwide (anastrozole, )

      Completed
      • Breast Cancer
      • Newcastle, New South Wales, Australia
      • +73 more
      Oct 5, 2021

      Lupus Nephritis Trial in Philippines, Taiwan (ANX009)

      Recruiting
      • Lupus Nephritis
      • ANX009
      • Angeles City, Philippines
      • +6 more
      Mar 10, 2023

      After Completing or Abandoning Hysterectomy in Cervical Cancer

      Completed
      • Uterine Cervical Neoplasms
      • Cervical procedure
      • Prague, MUDr., Czechia
        Gynecologic Oncology Center, Department of Obstetrics and Gyneco
      Aug 7, 2022

      The Lymphoid Tissue Pharmacology of Antiretroviral Drugs

      Not yet recruiting
      • HIV Infection
      • Anti-HIV Agents
      • (no location specified)
      Nov 4, 2022

      SGLT2 INHIBITORS, Lupus Nephritis, BMD Trial in Mansoura (Dapagliflozin tablet, )

      Active, not recruiting
      • SGLT2 INHIBITORS
      • +2 more
      • Dapagliflozin tablet
      • placebo
      • Mansoura, Egypt
        Urology and Nephrology Center
      Jan 19, 2023

      Colon Cancer, Sentinel Lymph Node Trial in Gent (ICG-nanocoll (indocyanine green coupled to the human albumin colloidal particle

      Recruiting
      • Colon Cancer
      • Sentinel Lymph Node
      • ICG-nanocoll (indocyanine green coupled to the human albumin colloidal particle nanocoll)
      • Gent, Belgium
        Ghent University Hospital
      Dec 9, 2022

      Precision Medicine in LN: A Multicenter Proof-of-concept Study

      Recruiting
      • Lupus Nephritis
      • Systemic Lupus Erythematosus
        • Vigo, Pontevedra, Spain
          IRIDIS-VIGO Group (Investigation in Rheumatology and Immune-Medi
        Apr 28, 2022

        Lupus Nephritis Trial in China (efgartigimod IV, Placebo)

        Recruiting
        • Lupus Nephritis
        • efgartigimod IV
        • Placebo
        • Beijing, China
        • +9 more
        Apr 11, 2023